In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental members will be enrolled with the discovered monotherapy dosign program. In Segment B, participants will obtain oral ruxolitinib and ABBV-744 are going to be offered as "insert-on" therapy. In Phase https://lorenzodsdoa.blogsuperapp.com/32611457/little-known-facts-about-abbv-744-as-a-potential-therapeutic-option-for-aggressive-cancers